Last Posted: Apr 30, 2020
- Association of Rare Pathogenic DNA Variants for Familial Hypercholesterolemia, Hereditary Breast and Ovarian Cancer Syndrome, and Lynch Syndrome With Disease Risk in Adults According to Family History
AP Patel, JAMA Network Open, April 29, 2020 - Association of premenopausal risk-reducing salpingo-oophorectomy with breast cancer risk in BRCA1/2 mutation carriers: Maximising bias-reduction.
Stjepanovic Neda et al. European journal of cancer (Oxford, England : 1990) 2020 Apr 13253-60 - BRCA1 and BRCA2 mutations in a sample of breast and ovarian cancer families from the Colombian pacific.
Cifuentes-C Laura et al. Colombia medica (Cali, Colombia) 2019 Sep 50(3) 163-175 - Negotiating jurisdictional boundaries in response to new genetic possibilities in breast cancer care: The creation of an 'oncogenetic taskscape'.
Wright Sarah et al. Social science & medicine (1982) 2019 22526-33 - Mainstream consent programs for genetic counseling in cancer patients: A systematic review.
Scheinberg Tahlia et al. Asia-Pacific journal of clinical oncology 2020 Apr - Germline Testing for Patients With BRCA1/2 Mutations on Somatic Tumor Testing.
Vlessis Katherine et al. JNCI cancer spectrum 2020 Feb 4(1) pkz095 - Pioneering Informed Consent for Return of Research Results to Breast Cancer Patients Facing Barriers to Implementation of Genomic Medicine: The Kenyan BRCA1/2 Testing Experience Using Whole Exome Sequencing.
Torrorey-Sawe Rispah et al. Frontiers in genetics 2020 11170 - Population-based genetic testing for Women's cancer prevention.
Evans Olivia et al. Best practice & research. Clinical obstetrics & gynaecology 2020 Mar - I Have a BRCA1 Gene Mutation: The Extra Stress of COVID-19 Takes a Toll
N McCoy, blog April 2, 2020 - Breast Conserving Surgery for BRCA Mutation Carriers-A Systematic Review.
Co Michael et al. Clinical breast cancer 2019 Aug
.png)
No hay comentarios:
Publicar un comentario